Expert Review of Hematology
Expert Review of Hematology is a journal indexed in SJR in Hematology with an H index of 58. It has a price of 4000 €. It has an SJR impact factor of 0,724 and it has a best quartile of Q2. It has an SJR impact factor of 0,724.
Metrics
Scimago and CountryOfPapers database fields
SJR Impact
0,724
H-index
58
Docs (year)
97
Docs 3y
326
Total refs
6940
Cites 3y
724
Citable 3y
299
Cites/Doc 2y
2.02
Ref/Doc
71.55
Immediate OA
4000 €
Embargoed OA
NPD
Non OA / Submission
0 €
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Researcher reviews
Best articles by citations
Bone morbidity in chronic myeloproliferative neoplasms
View moreWhen to treat patients with relapsed follicular lymphoma
View moreDetection of mild inherited disorders of blood coagulation: current options and personal recommendations
View moreDesign of the INHIBIT trial: preventing inhibitors by avoiding 'danger', prolonging half-life and promoting tolerance
View moreDecision-making in the management of adult classical Hodgkin's lymphoma: determining the optimal treatment
View moreDarbepoetin alfa for anemia with myelodysplastic syndrome
View moreCurrent strategies for treatment of relapsed/refractory multiple myeloma
View moreCommunications on multiple myeloma
View moreCombining proteasome with cell cycle inhibitors: a dual attack potentially applicable to multiple hematopoietic malignancies
View moreChimeric antigen receptor T cells: power tools to wipe out leukemia and lymphoma
View moreCD20-negative diffuse large B-cell lymphomas: biology and emerging therapeutic options
View moreBrentuximab vedotin in T-cell lymphoma
View moreBosutinib: a dual SRC/ABL kinase inhibitor for the treatment of chronic myeloid leukemia
View more2nd International Congress on Leukemia, Lymphoma and Myeloma
View moreAxl inhibition: a potential road to a novel acute myeloid leukemia therapy?
View moreAtherosclerosis, venous thromboembolism and migraine: what are the associated risks?
View moreAntigen-specific immunotherapy for acute myeloid leukemia: where are we now, and where do we go from here?
View moreAnti-infective prophylaxis in pediatric patients with acute myeloid leukemia
View moreAnemia in children: prevalence, causes, diagnostic work-up, and long-term consequences
View moreAmerican Society of Hematology Annual Meeting 2014: highlights in multiple myeloma
View moreAdult T-cell leukemia-lymphoma: current treatment strategies and novel immunological approaches
View moreAdult T-cell acute lymphoblastic leukemia: prognostic impact of myeloid-associated antigens
View moreAcute erythroleukemia: diagnosis and management
View moreA systematic literature review and indirect comparison of iron isomaltoside and ferric carboxymaltose in iron deficiency anemia after failure or intolerance of oral iron treatment
View more